EP0975337A2 — Fast release compressed tablet of flurbiprofen
Assigned to Reckitt Benckiser Healthcare UK Ltd · Expires 2000-02-02 · 26y expired
What this patent protects
A fast-release homogeneous compressed tablet composition comprising: (i) 1-50 % by weight flurbiprofen or a pharmaceutically acceptable salt thereof; and (ii) 50-99 % by weight compressible carrier material comprising a disintegrant and a compressible component selected from a su…
USPTO Abstract
A fast-release homogeneous compressed tablet composition comprising: (i) 1-50 % by weight flurbiprofen or a pharmaceutically acceptable salt thereof; and (ii) 50-99 % by weight compressible carrier material comprising a disintegrant and a compressible component selected from a sugar component, a starch component and an alkaline earth metal component; characterised in that the compressible carrier material further comprises microcrystalline cellulose present in a ratio to said compressible component of 1:4 to 4:1 parts by weight; and further characterised in that the crushing strength of the tablet is in the range 5-15 Kgf and that the disintegration time is less than 10 minutes.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.